Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

By Pariser David   Gordon Kenneth   Papp Kim   Leonardi Craig   Kwon Paul   Compton Peter   Rundle Amy   Walicke Patricia   Lebwohl Mark  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 303-312

Springer Publishing Company

Access to resources Recommend Favorite

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial

By Shikiar Richard   Heffernan Michael   Langley Richard   Willian Mary   Okun Martin   Revicki Dennis  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 25-31

Informa Healthcare

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of oral itraconazole in scalp psoriasis

By Jury CS   McHugh L   Shankland GS   Burden AD  

Journal of Dermatological Treatment, Vol. 11, Iss. 2, 2000-06 ,pp. : 85-89

Informa Healthcare

Access to resources Recommend Favorite

Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor

By Groot Marjan   Teunissen Marcel   Ortonne Jean   Lambert Julien   Naeyaert Jean   Picavet Daisy   Arreaza M.   Simon Jason   Kraan Maarten   Bos Jan   Rie Menno  

Archives of Dermatological Research, Vol. 299, Iss. 7, 2007-09 ,pp. : 305-313

Springer Publishing Company

Access to resources Recommend Favorite

A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis

By Saraswat Abir   Agarwal Ravindra   Katare Om   Kaur Inderjeet   Kumar Bhushan  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 40-45

Informa Healthcare

Access to resources Recommend Favorite